Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lea, Maillat"'
Autor:
Aymeric Auger, Laura Santambrogio, Patricia Corthésy, Davide Demurtas, Emanuela Romano, Melody A. Swartz, Lambert Potin, Maurice Matter, Cristina C. Clement, Romain Hamelin, Alexandre Harari, Daniel E. Speiser, Natacha Bordry, Lea Maillat, Maria A. S. Broggi
Publikováno v:
The Journal of Experimental Medicine
The Journal of experimental medicine, vol. 216, no. 5, pp. 1091-1107
The Journal of experimental medicine, vol. 216, no. 5, pp. 1091-1107
Identifying cancer biomarkers is of great interest for patient prognosis and monitoring. However, tumor-associated factors are diluted in blood and challenging to detect. Broggi et al. show that lymphatic exudate, accessible at the time of lymphadene
Autor:
Jun Ishihara, Kiyomitsu Katsumata, Eiji Yuba, Ako Ishihara, Jeffrey A. Hubbell, Peyman Hosseinchi, Melody A. Swartz, Joseph W. Reda, Aslan Mansurov, Elyse A. Watkins, Andrew C Tremain, Ani Solanki, Aaron T. Alpar, Erica Budina, Lea Maillat, Takahiro Kageyama, Mindy Nguyen
Interleukin-4 (IL-4) suppresses the development of multiple sclerosis in a murine model of experimental autoimmune encephalomyelitis (EAE). Here, we show that, in mice with EAE, the accumulation and persistence in the lymph nodes and spleen of a syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cc2c54ec773f6e2b7177fa901442dd6
http://hdl.handle.net/10044/1/83460
http://hdl.handle.net/10044/1/83460
Autor:
Sweta Sharma-Saha, Yamuna Krishnan, Lea Maillat, Kaela Bynoe, Walter M. Stadler, Brian L. Heiss, Priyanka Dutta Gupta, Kiranj K. Chaudagar, Ka-Ho Leung, Akash Patnaik
Publikováno v:
Cancer Research. 81:1685-1685
There has been a resurgent interest in prostate cancer (PC) immunotherapy, partly based on the profound and durable clinical responses to immune checkpoint blockade (ICB) antibodies targeting CTLA-4 and PD-1/PD-L1 in multiple other cancers, and partl
Autor:
Ako, Ishihara, Jun, Ishihara, Elyse A, Watkins, Andrew C, Tremain, Mindy, Nguyen, Ani, Solanki, Kiyomitsu, Katsumata, Aslan, Mansurov, Erica, Budina, Aaron T, Alpar, Peyman, Hosseinchi, Lea, Maillat, Joseph W, Reda, Takahiro, Kageyama, Melody A, Swartz, Eiji, Yuba, Jeffrey A, Hubbell
Publikováno v:
Nature biomedical engineering. 5(5)
Interleukin-4 (IL-4) suppresses the development of multiple sclerosis in a murine model of experimental autoimmune encephalomyelitis (EAE). Here, we show that, in mice with EAE, the accumulation and persistence in the lymph nodes and spleen of a syst
Autor:
Ako Ishihara, Takahiro Kageyama, Eiji Yuba, Joseph W. Reda, Aslan Mansurov, Jun Ishihara, Mindy Nguyen, Aaron T. Alpar, Kiyomitsu Katsumata, Erica Budina, Lea Maillat, Ani Solanki, Andrew C Tremain, Peyman Hosseinchi, Melody A. Swartz, Elyse A. Watkins, Jeffrey A. Hubbell
Publikováno v:
Nature Biomedical Engineering. 4:1117-1117
Autor:
Gavin Fujimori, Aslan Mansurov, Jeffrey A. Hubbell, Melody A. Swartz, Peyman Hosseinchi, Lambert Potin, Lea Maillat
Publikováno v:
Cancer Research. 80:5695-5695
Growth and remodeling of tumor-associated lymphatics, termed lymphangiogenesis, has been known to increase metastasis rate in cancer patients. However, a recent study from our group has shown that tumor-associated lymphatics can improve anti-tumor im
Autor:
Jeffrey A. Hubbell, Lea Maillat, Lambert Potin, Peyman Hosseinchi, Melody A. Swartz, Aslan Mansurov
Publikováno v:
Cancer Immunology Research. 8:B97-B97
During cancer development, growth and remodeling of lymphatic vessels—termed lymphangiogenesis—is associated with increased metastasis rate. However, our group has recently shown that lymphangiogenesis can also increase tumor immune infiltration
Publikováno v:
Cancer Research. 79:4520-4520
Prior to metastasis, tumor-draining lymph nodes and distant organs are altered by a number of tumor-derived factors that help to both suppress host immunity as well as form an environment that supports metastatic tumor cells, i.e., a pre-metastatic n
Publikováno v:
Cancer Research. 78:1750-1750
Tumor-associated lymphangiogenesis is well known to promote metastasis and to correlate with poor prognosis in melanoma and other cancers, yet its functional roles in antitumor immunity had remained largely unexplored. In a recent study, we investiga
Autor:
Tao Sun, Joel H. Collier, Rebecca R. Pompano, Jianjun Chen, Anita S. Chong, Felix W. Santiago, Huifang Han, Roger Sciammas, David J. Topham, Lea Maillat
Publikováno v:
Biomaterials, vol 34, iss 34
Balancing immunogenicity with inflammation is a central tenet of vaccine design, especially for subunit vaccines that utilize traditional pro-inflammatory adjuvants. Here we report that by using a nanoparticulate peptide-based vaccine, immunogenicity